Tumor length as a prognostic factor in esophageal malignancy: Univariate and multivariate survival analyses

Journal of Histotechnology

Volumn 28, Issue 4, 2006, Pages 258-267

  Griffiths, Ewen A ^a   Brummell, Zoe ^a   Gorthi, Ganesh ^a   Pritchard, Susan A ^a   McL Welch, Ian ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Esophageal cancer; Survival; Tumor length

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; TUMOR DIFFERENTIATION; TUMOR VOLUME; UNIVARIATE ANALYSIS; ADENOCARCINOMA; BIOASSAY; ESOPHAGUS TUMOR; FOLLOW UP; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ENDPOINT DETERMINATION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33644671505     PISSN: 01478885     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20449     Document Type: Article

References (31)

1. Blot WJ, Devesa SS, Kneller RW, et al.: Rising incidence of adenocarcinoma of the esophagus and gastric cardia. Jama 1991;265:1287-1289.
2. Thomas P, Doddoli C, Lienne P, et al.: Changing patterns and surgical results in adenocarcinoma of the oesophagus. Br J Surg 1997;84:119-125.
3. Rice TW, Blackstone EH, Rybicki LA, et al.: Refining esophageal cancer staging. J Thorac Cardiovasc Surg 2003;125:1103-1113.
4. Siewert JR, Stein HJ, Feith M, et al.: Histologic tumor type is an independent prognostic parameter in esophageal cancer: Lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 2001;234:360-367; discussion 368-369.
5. Eloubeidi MA, Desmond R, Arguedas MR, et al.: Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: The importance of tumor length and lymph node status. Cancer 2002;95:1434-1443.
6. Langley SM, Alexiou C, Bailey DH, et al.: The influence of perioperative blood transfusion on survival after esophageal resection for carcinoma. Ann Thorac Surg 2002;73:1704-1709.
7. Dexter SP, Sue-Ling H, McMahon MJ, et al.: Circumferential resection margin involvement: An independent predictor of survival following surgery for oesophageal cancer. Gut 2001;48:667-670.
8. Law S, Arcilla C, Chu KM, et al.: The significance of histologically infiltrated resection margin after esophagectomy for esophageal cancer. Am J Surg 1998;176:286-290.
9. Robey-Cafferty SS, el-Naggar AK, Sahin AA, et al.: Prognostic factors in esophageal squamous carcinoma. A study of histologic features, blood group expression, and DNA ploidy. Am J Clin Pathol 1991;95:844-849.
10. Zafirellis K, Dolan K, Fountoulakis A, et al.: Multivariate analysis of clinical, operative and pathologic features of esophageal cancer: Who needs adjuvant therapy? Dis Esophagus 2002;15:155-159.
11. Tanaka A, Matsumura E, Yosikawa H, et al.: An evaluation of neural invasion in esophageal cancer. Surg Today 1998;28:873-878.
12. Slevin NJ, Stout R: Carcinoma of the oesophagus-A review of 108 cases treated by radical radiotherapy. Clin Radiol 1989;40:200-203.
13. Yamakawa M, Shiojima K, Takahashi M, et al.: Radiation therapy for esophageal cancer in patients over 80 years old. Int J Radiat Oncol Biol Phys 1994;30:1225-1232.
14. Sobin LHWC (ed): "International union against cancer (UICC): TNM Classification of malignant tumours." New York: Wiley-Liss, 1997.
15. Reed CE, Mishra G, Sahai AV, et al.: Esophageal cancer staging: Improved accuracy by endoscopic ultrasound of celiac lymph nodes. Ann Thorac Surg 1999;67:319-321; discussion 322.
16. Vazquez-Sequeiros E, Norton ID, Clain JE, et al.: Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma. Gastrointest Endosc 2001;53:751-757.
17. Bhutani MS, Barde CJ, Markert RJ, et al.: Length of esophageal cancer and degree of luminal stenosis during upper endoscopy predict T stage by endoscopic ultrasound. Endoscopy 2002;34:461-463.
18. Shinkai M, Niwa Y, Arisawa T, et al.: Evaluation of prognosis of squamous cell carcinoma of the oesophagus by endoscopic ultrasonography. Gut 2000;47:120-125.
19. Mapstone N (ed): "Minimum dataset for oesophageal carcinoma histopathology reports." London: Royal College of Pathologists, 1998.
20. Histological typing of gastric and oesophageal tumours. International histological classification of tumours, no 18. In: World Health Organisation., 1977.
21. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomised controlled trial. Lancet 2002;359:1727-1733.
22. Thompson WM: Esophageal cancer. Int J Radiat Oncol Biol Phys 1983;9:1533-1565.
23. Khan OA, Alexiou C, Soomro I, et al.: Pathological determinants of survival in node-negative oesophageal cancer. Br J Surg 2004;91:1586-1591.
24. Tachibana M, Dhar DK, Kinugasa S, et al.: Esophageal cancer patients surviving 6 years after esophagectomy. Langenbecks Arch Surg 2002;387:77-83.
25. Igaki H, Kato H, Tachimori Y, et al.: Prognostic evaluation for squamous cell carcinomas of the lower thoracic esophagus treated with three-field lymph node dissection. Eur J Cardiothorac Surg 2001;19:887-893.
26. Siu KF, Cheung HC, Wong J: Shrinkage of the esophagus after resection for carcinoma. Ann Surg 1986;203:173-176.
27. Rice TW, Vargo JJ, Goldblum JR, et al.: Endoscopic ultrasound errors in esophageal cancer. Am J Gastroenterol 2005;100:601-606.
28. Heeren PA, van Westreenen HL, Geersing GJ, et al.: Influence of tumor characteristics on the accuracy of endoscopic ultrasonography in staging cancer of the esophagus and esophagogastric junction. Endoscopy 2004;36:966-971.
29. Choi JY, Jang HJ, Shim YM, et al.: 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: Prognostic implications. J Nucl Med 2004;45:1843-1850.
30. Kato H, Kuwano H, Nakajima M, et al.: Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer 2002;94:921-928.
31. Wallace MB, Nietert PJ, Earle C, et al.: An analysis of multiple staging management strategies for carcinoma of the esophagus: Computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/ laparoscopy. Ann Thorac Surg 2002;74:1026-1032.